XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Cash, Cash Equivalents and Investments
6 Months Ended
Jun. 30, 2023
Cash, Cash Equivalents and Investments  
Cash, Cash Equivalents and Investments

4.           Cash, Cash Equivalents and Investments

The fair value and the amortized cost of cash, cash equivalents and available-for-sale investments by major security type consist of the following (in thousands):

Gross

Gross

Estimated

Cash and

 

Amortized

Unrealized

Unrealized

Fair

Cash

Short-term

 

June 30, 2023

    

Cost

    

Gains

    

Losses

    

Value

    

Equivalents

Investment

 

Cash, cash equivalents and money market funds

$

27,686

$

$

$

27,686

$

27,686

$

Available-for-sale:

U.S. Treasury securities

 

10,847

2

10,849

10,849

Total

$

38,533

$

2

$

$

38,535

$

27,686

$

10,849

Gross

Gross

Estimated

Cash and

 

Amortized

Unrealized

Unrealized

Fair

Cash

Short-term

 

December 31, 2022

    

Cost

    

Gains

    

Losses

    

Value

    

Equivalents

Investment

 

Cash, cash equivalents and money market funds

$

30,819

$

$

$

30,819

$

30,819

$

Available-for-sale:

U.S. Treasury securities

 

37,458

(261)

37,197

37,197

Corporate debt securities

1,999

(3)

1,996

1,996

Certificates of deposit

485

 

 

(2)

 

483

 

 

483

Total

$

70,761

$

$

(266)

$

70,495

$

30,819

$

39,676

The Company evaluated the securities for other-than-temporary impairment and considered the decline in market value for the securities to be primarily attributable to current economic and market conditions. It is not more likely than not that the Company will be required to sell the securities, and the Company has no intention to do so prior to the recovery of the amortized cost basis. Based on this analysis, these marketable securities were not considered to be other-than-temporarily impaired as of June 30, 2023.